CymitQuimica logo

CAS 86189-66-4

:

Idarubicinol

Description:
Idarubicinol, with the CAS number 86189-66-4, is a metabolite of idarubicin, an anthracycline antibiotic used primarily in cancer treatment. It exhibits similar pharmacological properties to its parent compound, including antitumor activity, but with a different pharmacokinetic profile. Idarubicinol is characterized by its ability to intercalate DNA, thereby inhibiting topoisomerase II, which is crucial for DNA replication and repair. This mechanism leads to the disruption of cancer cell proliferation. The substance is typically administered intravenously and is known for its potential side effects, including cardiotoxicity, which is a common concern with anthracycline derivatives. Idarubicinol is also notable for its solubility in organic solvents, which facilitates its formulation for therapeutic use. Its efficacy and safety profile make it a subject of ongoing research, particularly in the context of hematological malignancies and solid tumors. Overall, idarubicinol represents an important compound in the field of oncology, contributing to the arsenal of chemotherapeutic agents available for cancer treatment.
Formula:C26H29NO9
InChI:InChI=1S/C26H29NO9/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31/h3-6,10-11,15-17,21,28-29,32-34H,7-9,27H2,1-2H3/t10-,11-,15-,16-,17-,21+,26-/m0/s1
InChI key:InChIKey=KMIBSUUWQWSRQV-BAYOIBAISA-N
SMILES:O([C@@H]1C2=C(C(O)=C3C(=C2O)C(=O)C=4C(C3=O)=CC=CC4)C[C@]([C@H](C)O)(O)C1)[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5
Synonyms:
  • 5,12-Naphthacenedione, 7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(1-hydroxyethyl)-, [7S-[7α,9α,9(R*)]]-
  • 5,12-Naphthacenedione, 7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-[(1S)-1-hydroxyethyl]-, (7S,9S)-
  • 4-Demethoxydaunorubicinol
  • (7S,9S)-7-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-[(1S)-1-hydroxyethyl]-5,12-naphthacenedione
  • Antibiotic FCE 22723
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
  • Idarubicinol

    CAS:
    Formula:C26H29NO9
    Molecular weight:499.52

    Ref: 4Z-I-055003

    5mg
    To inquire
    10mg
    To inquire
    25mg
    To inquire
    50mg
    To inquire
    100mg
    To inquire
  • Idarubicinol-d4 (Mixture of Diastereomers) (>80%)

    Controlled Product
    CAS:
    <p>Stability Hygroscopic<br>Applications Labelled Idarubicinol is the alcohol analog of Idrabucin (I167000), an orally active anthracycline; analog of Daunorubicin. Antineoplastic.<br>References Arcamone, F., et al.: Caner Treat. Rep., 60, 829 (1976), Zini, G., et al.: Cancer Chemother. Pharmacol., 16, 107 (1986), Gillies, H.C., et al.: Br.J. Clin. Pharmacol., 23, 303 (1987), Villani, F., et al.: Eur. J. Cancer Clin. Oncol., 25, 13 (1989),<br></p>
    Formula:C26D4H25NO9
    Purity:>80%
    Color and Shape:Neat
    Molecular weight:503.53

    Ref: TR-I167022

    1mg
    4,889.00€
    250µg
    1,491.00€
  • Idarubicinol (Mixture of Diastereomers)

    CAS:
    <p>Stability Hygroscopic<br>Applications Idarubicinol is the alcohol analog of Idrabucin (I167000), an orally active anthracycline; analog of Daunorubicin. Antineoplastic.<br>References Arcamone, F., et al.: Caner Treat. Rep., 60, 829 (1976), Zini, G., et al.: Cancer Chemother. Pharmacol., 16, 107 (1986), Gillies, H.C., et al.: Br.J. Clin. Pharmacol., 23, 303 (1987), Villani, F., et al.: Eur. J. Cancer Clin. Oncol., 25, 13 (1989),<br></p>
    Formula:C26H29NO9
    Color and Shape:Neat
    Molecular weight:499.51

    Ref: TR-I167020

    5mg
    2,436.00€
    500µg
    366.00€
  • Idarubicinol

    CAS:
    <p>Idarubicinol is an analog of the anticancer drug idarubicin and is known for its potent apoptotic effects on cancer cells. It works by inhibiting protein kinases, which are enzymes that play a crucial role in cancer cell growth and division. Idarubicinol has been shown to be effective against a wide range of human cancers, including Chinese hamster ovary (CHO) tumors. This medicinal compound has been identified in urine samples from patients undergoing chemotherapy with idarubicin, indicating that it may play a role in the treatment of cancer. As an inhibitor of kinases, Idarubicinol has potential as a therapeutic agent for the treatment of various types of cancer.</p>
    Formula:C26H29NO9
    Purity:Min. 95%
    Molecular weight:499.5 g/mol

    Ref: 3D-LDA18966

    5mg
    1,674.00€
    10mg
    2,609.00€
    25mg
    4,891.00€
    50mg
    7,825.00€